中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Returns - Share Buyback
2021-11-02
Next Day Disclosure Returns - Share Buyback
2021-11-01
Voluntary Announcement - Gannex Announces U.S. IND Approval of ASC43F, a First-in-class Dual-target fixed-Dose Combination for NASH
2021-11-01
Next Day Disclosure Returns - Share Buyback
2021-10-29
Next Day Disclosure Returns - Share Buyback
2021-10-28
Next Day Disclosure Returns - Share Buyback
2021-10-27
Next Day Disclosure Returns - Share Buyback
2021-10-26
Next Day Disclosure Returns - Share Buyback
2021-10-25
Next Day Disclosure Returns - Share Buyback
2021-10-22
Next Day Disclosure Returns - Share Buyback
2021-10-21
«
5
6
7
8
»